Pancreas
Pancreas Transplant Clinical Trials
Current Clinical Trials
Islet transplantation in type 1 diabetes using immunosuppression and strategies to improve long term graft survival
Principal Investigator: Ali Naji, MD
Sponsor: National Institutes of Health
Using anti-B lymphocyte agent rituximab (Rituxan) to improve long term graft survival
Principal Investigator: Ali Naji, MD
Sponsor: National Institutes of Health
Islet transplantation vs. intensive insulin therapy in patients with type 1 diabetes who have already received a kidney transplant
Principal Investigator: Ali Naji, MD
Sponsor: National Institutes of Health
For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.
|
Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor. |
|
|


